Tag: ProKidney Corp.

[breadcrumb_custom]

Company

ProKidney Corp (NASDAQ: PROK) Shares Could Drop Up To -481.4%

In today’s recent session, 1.45 million shares of the ProKidney Corp (NASDAQ:PROK) have been traded, and its beta is 1.06. Most recently the company’s share

Technologies

ProKidney Corp (NASDAQ:PROK) Is Worth Considering At $2.84

ProKidney Corp (NASDAQ:PROK)’s traded shares stood at 3.43 million during the last session, with the company’s beta value hitting 0.92. At the close of trading,

Business

How To Know If ProKidney Corp (NASDAQ:PROK) Is Expensive At $1.64.

In last trading session, ProKidney Corp (NASDAQ:PROK) saw 2.88 million shares changing hands with its beta currently measuring 1.31. Company’s recent per share price level

Science

ProKidney Corp (NASDAQ: PROK) Is Up 24.83% From Its 52-Week Low; YTD, It Is Down -16.29% – What To Do Now

During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 1.01 million, with the beta value of the company hitting 1.29. At the end of

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: ProKidney Corp.

ProKidney Corp (NASDAQ: PROK) Shares Could Drop Up To -481.4%

ProKidney Corp (NASDAQ:PROK) Is Worth Considering At $2.84

How To Know If ProKidney Corp (NASDAQ:PROK) Is Expensive At $1.64.

ProKidney Corp (NASDAQ: PROK) Is Up 24.83% From Its 52-Week Low; YTD, It Is Down -16.29% – What To Do Now

Categories

Quick links